A Case Study on EEG Analysis: Embedding Entropy Estimations Indicate the Decreased Neuro-Cortical Complexity Levels Mediated by Methylphenidate Treatment in Children with ADHD
Restricted accessResearch articleFirst published online September, 2022
A Case Study on EEG Analysis: Embedding Entropy Estimations Indicate the Decreased Neuro-Cortical Complexity Levels Mediated by Methylphenidate Treatment in Children with ADHD
Objective: Complexity analysis is a method employed to understand the activity of the brain. The effect of methylphenidate (MPH) treatment on neuro-cortical complexity changes is still unknown. This study aimed to reveal how MPH treatment affects the brain complexity of children with attention deficit hyperactivity disorder (ADHD) using entropy-based quantitative EEG analysis. Three embedding entropy approaches were applied to short segments of both pre- and post- medication EEG series. EEG signals were recorded for 25 boys with combined type ADHD prior to the administration of MPH and at the end of the first month of the treatment. Results: In comparison to Approximate Entropy (ApEn) and Sample Entropy (SampEn), Permutation Entropy (PermEn) provided the most sensitive estimations in investigating the impact of MPH treatment. In detail, the considerable decrease in EEG complexity levels were observed at six cortical regions (F3, F4, P4, T3, T6, O2) with statistically significant level (p < .05). As well, PermEn provided the most meaningful associations at central lobes as follows: 1) The largeness of EEG complexity levels was moderately related to the severity of ADHD symptom detected at pre-treatment stage. 2) The percentage change in the severity of opposition as the symptom cluster was moderately reduced by the change in entropy. Conclusion: A significant decrease in entropy levels in the frontal region was detected in boys with combined type ADHD undergoing MPH treatment at resting-state mode. The changes in entropy correlated with pre-treatment general symptom severity of ADHD and conduct disorder symptom cluster severity.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Pub; 2013.
2.
ZimmerL. Contribution of clinical neuroimaging to the understanding of the pharmacology of methylphenidate. Trends Pharmacol Sci.Jul 2017;38(7):608-620.
WolraichMLChanEFroehlichT, et al.ADHD Diagnosis and treatment guidelines: a historical perspective. Pediatrics.Oct 2019;144(4):e20191682.
5.
HussMDuhanPGandhiPChenCWSpannhuthCKumarV. Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity. Neuropsychiatr Dis Treat.2017;13:1741-1751.
6.
FernandezAMendezMAHorneroROrtizTLopez-IborJJ. Analysis of brain complexity and mental disorders. Actas Esp Psiquiatr.Jul-Aug 2010;38(4):229-238.
7.
StamCJ. Nonlinear dynamical analysis of EEG and MEG: review of an emerging field. Clin Neurophysiol.Oct 2005;116(10):2266-2301.
8.
YaoYLuWLXuB, et al.The increase of the functional entropy of the human brain with Age. Sci Rep.Oct 9 2013;3:2853.
9.
TakahashiT. Complexity of spontaneous brain activity in mental disorders. Prog Neuropsychopharmacol Biol Psychiatry. Aug 1 2013;45:258-266.
10.
TakahashiTChoRYMizunoT, et al.Antipsychotics reverse abnormal EEG complexity in drug-naive schizophrenia: a multiscale entropy analysis. Neuroimage. May 15 2010;51(1):173-182.
11.
ErogluGGurkanMTeberS, et al.Changes in EEG complexity with neurofeedback and multi-sensory learning in children with dyslexia: a multiscale entropy analysis. Appl Neuropsychol Child. Jun 9 2020:1-12.
12.
CaoYHTungWWGaoJBProtopopescuVAHivelyLM. Detecting dynamical changes in time series using the permutation entropy. Physical Review E.Oct 2004;70(4):046217.
13.
GuYMiaoSHanJ, et al.Complexity analysis of fNIRS signals in ADHD children during working memory task. Sci Rep. Apr 11 2017;7(1):829.
14.
ChowJCOuyangCSTsaiCL, et al.Entropy-Based quantitative electroencephalogram analysis for diagnosing attention-deficit hyperactivity disorder in girls. Clin EEG Neurosci.May 2019;50(3):172-179.
15.
KhoshnoudSNazariMAShamsiM. Functional brain dynamic analysis of ADHD and control children using nonlinear dynamical features of EEG signals. J Integr Neurosci.2018;17(1):11-17.
16.
TimmermannDLZimmermanAWMuenchenRA. Methylphenidate effects on EEG, behavior, and performance in boys with ADHD. Pediatr Neurol.1998;18(3):244-250.
17.
LubarJFWhite JrJNSwartwoodMOSwartwoodJN. Methylphenidate effects on global and complex measures of EEG. Pediatr Neurol.1999;21(3):633-637.
18.
ChabotRJOrgillAACrawfordGHarrisMJSerfonteinG. Behavioral and electrophysiologic predictors of treatment response to stimulants in children with attention disorders. J Child Neurol.1999;14(6):343-351.
19.
BarryRJClarkeARHajosMMcCarthyRSelikowitzMBruggemannJM. Acute atomoxetine effects on the EEG of children with attention-deficit/hyperactivity disorder. Neuropharmacology.2009;57(7-8):702-707.
20.
DupuyFClarkeABarryRSelikowitzMMcCarthyR. EEG And electrodermal activity in girls with attention-deficit/hyperactivity disorder. Clin Neurophysiol.2014;125(3):491-499.
21.
BarryRJClarkeARHajosMMcCarthyRSelikowitzMDupuyFE. Resting-state EEG gamma activity in children with attention-deficit/hyperactivity disorder. Clin Neurophysiol.2010;121(11):1871-1877.
22.
MowlemFDRosenqvistMAMartinJLichtensteinPAshersonPLarssonH. Sex differences in predicting ADHD clinical diagnosis and pharmacological treatment. Eur Child Adolesc Psychiatry.Apr 2019;28(4):481-489.
23.
TurgayA. Disruptive behavior disorders child and adolescent screening and rating scales for children, adolescents, parents and teachers. West Bloomfield (Michigan): Integrative Therapy Institute Publication.1994.
24.
ErcanE. Development of a test battery for the assessment of attention deficit hyperactivity disorder. Turk J Child Adolesc Psychiatry.2001;8:132-144.
25.
KaufmanJBirmaherBBrentD, et al.Schedule for affective disorders and schizophrenia for school-Age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry.Jul 1997;36(7):980-988.
26.
GoklerB. Reliability and validity of schedule for affective disorders and schizophrenia for school age children-present and lifetime version-turkish version (K-SADS-PL-T)[in turkish]. Turk J Child Adolesc Mental Health.2004;11:109-116.
27.
RubiaKAlegriaABrinsonH. Imaging the ADHD brain: disorder-specificity, medication effects and clinical translation. Expert Rev Neurother.May 2014;14(5):519-538.
28.
VillemonteixTDe BritoSAKavecM, et al.Grey matter volumes in treatment naive versus chronically treated children with attention deficit/hyperactivity disorder: a combined approach. Eur Neuropsychopharmacol.Aug 2015;25(8):1118-1127.
29.
RubiaKHalariRCubilloA, et al.Methylphenidate normalizes fronto-striatal underactivation during interference inhibition in medication-naive boys with attention-deficit hyperactivity disorder. Neuropsychopharmacology.Jul 2011;36(8):1575-1586.
30.
RubiaKHalariRMohammadAMTaylorEBrammerM. Methylphenidate normalizes frontocingulate underactivation during error processing in attention-deficit/hyperactivity disorder. Biol Psychiatry. Aug 1 2011;70(3):255-262.
31.
RubiaKHalariRCubilloAMohammadAMBrammerMTaylorE. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naive children with ADHD during a rewarded continuous performance task. Neuropharmacology.Dec 2009;57(7-8):640-652.
32.
LeeYSHanDHLeeJHChoiTY. The effects of methylphenidate on neural substrates associated with interference suppression in children with ADHD: a preliminary study using event related fMRI. Psychiatry Investig.Mar 2010;7(1):49-54.
33.
EpsteinJNCaseyBJTonevST, et al.ADHD- and medication-related brain activation effects in concordantly affected parent-child dyads with ADHD. Journal of Child Psychology and Psychiatry.Sep 2007;48(9):899-913.
34.
RaichleME. The Brain's Default mode network. Annu Rev Neurosci.2015;38:433-447.
35.
HartHRaduaJMataix-ColsDRubiaK. Meta-analysis of fMRI studies of timing in attention-deficit hyperactivity disorder (ADHD). Neurosci Biobehav Rev.Nov 2012;36(10):2248-2256.
36.
BroydSJDemanueleCDebenerSHelpsSKJamesCJSonuga-BarkeEJ. Default-mode brain dysfunction in mental disorders: a systematic review. Neurosci Biobehav Rev.Mar 2009;33(3):279-296.
37.
CorteseSKellyCChabernaudC, et al.Toward systems neuroscience of ADHD: a meta-analysis of 55 fMRI studies. Am J Psychiatry.Oct 2012;169(10):1038-1055.
38.
ChenxiLChenYLiYWangJLiuT. Complexity analysis of brain activity in attention-deficit/hyperactivity disorder: a multiscale entropy analysis. Brain Res Bull.Jun 2016;124:12-20.
39.
TakahashiTChoRYMurataT, et al.Age-related variation in EEG complexity to photic stimulation: a multiscale entropy analysis. Clin Neurophysiol.Mar 2009;120(3):476-483.
40.
LiXLCuiSYVossLJ. Using permutation entropy to measure the electroencephalographic effects of sevoflurane. Anesthesiology.Sep 2008;109(3):448-456.
41.
LiXOuyangGRichardsDA. Predictability analysis of absence seizures with permutation entropy. Epilepsy Res.Oct 2007;77(1):70-74.
42.
BuyckIWiersemaJR. Resting electroencephalogram in attention deficit hyperactivity disorder: developmental course and diagnostic value. Psychiatry Res. May 30 2014;216(3):391-397.
43.
SohnHKimILeeW, et al.Linear and non-linear EEG analysis of adolescents with attention-deficit/hyperactivity disorder during a cognitive task. Clin Neurophysiol.Nov 2010;121(11):1863-1870.
